Cargando…

Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets

Background: Pharmacological neuroenhancement (PN) is defined as the use of illicit or prescription drugs by healthy individuals for cognitive-enhancing purposes. The present study aimed (i) to investigate whether including caffeine tablets in the definition of PN within a questionnaire increases the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, Pavel, Iberl, Benedikt, Schuett, Emanuel, van Poppel, Mireille, Ulrich, Rolf, Sattler, Matteo Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006370/
https://www.ncbi.nlm.nih.gov/pubmed/29946254
http://dx.doi.org/10.3389/fphar.2018.00494
_version_ 1783332826417987584
author Dietz, Pavel
Iberl, Benedikt
Schuett, Emanuel
van Poppel, Mireille
Ulrich, Rolf
Sattler, Matteo Christian
author_facet Dietz, Pavel
Iberl, Benedikt
Schuett, Emanuel
van Poppel, Mireille
Ulrich, Rolf
Sattler, Matteo Christian
author_sort Dietz, Pavel
collection PubMed
description Background: Pharmacological neuroenhancement (PN) is defined as the use of illicit or prescription drugs by healthy individuals for cognitive-enhancing purposes. The present study aimed (i) to investigate whether including caffeine tablets in the definition of PN within a questionnaire increases the PN prevalence estimate (framing effect), (ii) to investigate whether the health-related risk attitude is increased in students who use PN. Materials and methods: Two versions of a paper-and-pencil questionnaire (first version included caffeine tablets in the definition of PN, the second excluded caffeine tablets) were distributed among university students at the University of Graz, Austria. The unrelated question model (UQM) was used to estimate the 12-month PN prevalence and the German version of the 30-item Domain-Specific Risk-Taking (DOSPERT) scale to assess the health-related risk attitude. Moreover, large-sample z-tests (α = 0.05) were performed for comparing the PN prevalence estimates of two groups. Results: Two thousand four hundred and eighty-nine questionnaires were distributed and 2,284 (91.8%) questionnaires were included in analysis. The overall PN prevalence estimate for all students was 11.9%. One-tailed large-sample z-tests revealed that the PN estimate for students with higher health-related risk attitude was significantly higher compared to students with lower health-related risk attitude (15.6 vs. 8.5%; z = 2.65, p = 0.004). Furthermore, when caffeine tablets were included into the example of PN, the prevalence estimate of PN was significantly higher compared to the version without caffeine tablets (14.9 vs. 9.0%; z = 2.20, p = 0.014). Discussion: This study revealed that the PN prevalence estimate increases when caffeine tablets are included in the definition of PN. Therefore, future studies investigating the prevalence of, and predictors for, PN should be performed and interpreted with respect to potential framing effects. This study further revealed that the PN prevalence estimate is increased in students with a higher health-related risk attitude compared to students with a lower one. Therefore, future education and prevention programs addressing PN in the collective of students should not only inform about potential side effects of its use but also address the limited effects on cognition and potential alternatives of PN.
format Online
Article
Text
id pubmed-6006370
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60063702018-06-26 Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets Dietz, Pavel Iberl, Benedikt Schuett, Emanuel van Poppel, Mireille Ulrich, Rolf Sattler, Matteo Christian Front Pharmacol Pharmacology Background: Pharmacological neuroenhancement (PN) is defined as the use of illicit or prescription drugs by healthy individuals for cognitive-enhancing purposes. The present study aimed (i) to investigate whether including caffeine tablets in the definition of PN within a questionnaire increases the PN prevalence estimate (framing effect), (ii) to investigate whether the health-related risk attitude is increased in students who use PN. Materials and methods: Two versions of a paper-and-pencil questionnaire (first version included caffeine tablets in the definition of PN, the second excluded caffeine tablets) were distributed among university students at the University of Graz, Austria. The unrelated question model (UQM) was used to estimate the 12-month PN prevalence and the German version of the 30-item Domain-Specific Risk-Taking (DOSPERT) scale to assess the health-related risk attitude. Moreover, large-sample z-tests (α = 0.05) were performed for comparing the PN prevalence estimates of two groups. Results: Two thousand four hundred and eighty-nine questionnaires were distributed and 2,284 (91.8%) questionnaires were included in analysis. The overall PN prevalence estimate for all students was 11.9%. One-tailed large-sample z-tests revealed that the PN estimate for students with higher health-related risk attitude was significantly higher compared to students with lower health-related risk attitude (15.6 vs. 8.5%; z = 2.65, p = 0.004). Furthermore, when caffeine tablets were included into the example of PN, the prevalence estimate of PN was significantly higher compared to the version without caffeine tablets (14.9 vs. 9.0%; z = 2.20, p = 0.014). Discussion: This study revealed that the PN prevalence estimate increases when caffeine tablets are included in the definition of PN. Therefore, future studies investigating the prevalence of, and predictors for, PN should be performed and interpreted with respect to potential framing effects. This study further revealed that the PN prevalence estimate is increased in students with a higher health-related risk attitude compared to students with a lower one. Therefore, future education and prevention programs addressing PN in the collective of students should not only inform about potential side effects of its use but also address the limited effects on cognition and potential alternatives of PN. Frontiers Media S.A. 2018-06-12 /pmc/articles/PMC6006370/ /pubmed/29946254 http://dx.doi.org/10.3389/fphar.2018.00494 Text en Copyright © 2018 Dietz, Iberl, Schuett, van Poppel, Ulrich and Sattler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Dietz, Pavel
Iberl, Benedikt
Schuett, Emanuel
van Poppel, Mireille
Ulrich, Rolf
Sattler, Matteo Christian
Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title_full Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title_fullStr Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title_full_unstemmed Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title_short Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
title_sort prevalence estimates for pharmacological neuroenhancement in austrian university students: its relation to health-related risk attitude and the framing effect of caffeine tablets
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006370/
https://www.ncbi.nlm.nih.gov/pubmed/29946254
http://dx.doi.org/10.3389/fphar.2018.00494
work_keys_str_mv AT dietzpavel prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets
AT iberlbenedikt prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets
AT schuettemanuel prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets
AT vanpoppelmireille prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets
AT ulrichrolf prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets
AT sattlermatteochristian prevalenceestimatesforpharmacologicalneuroenhancementinaustrianuniversitystudentsitsrelationtohealthrelatedriskattitudeandtheframingeffectofcaffeinetablets